AU2001253029A1 - T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer - Google Patents

T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Info

Publication number
AU2001253029A1
AU2001253029A1 AU2001253029A AU5302901A AU2001253029A1 AU 2001253029 A1 AU2001253029 A1 AU 2001253029A1 AU 2001253029 A AU2001253029 A AU 2001253029A AU 5302901 A AU5302901 A AU 5302901A AU 2001253029 A1 AU2001253029 A1 AU 2001253029A1
Authority
AU
Australia
Prior art keywords
mage
inducing
vectors
cancer
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253029A
Inventor
Maria Bettinotti
Francesco Marincola
Monica Panelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001253029A1 publication Critical patent/AU2001253029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001253029A 2000-03-30 2001-03-29 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer Abandoned AU2001253029A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19320600P 2000-03-30 2000-03-30
US60193206 2000-03-30
PCT/US2001/010312 WO2001074847A2 (en) 2000-03-30 2001-03-29 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Publications (1)

Publication Number Publication Date
AU2001253029A1 true AU2001253029A1 (en) 2001-10-15

Family

ID=22712651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253029A Abandoned AU2001253029A1 (en) 2000-03-30 2001-03-29 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Country Status (2)

Country Link
AU (1) AU2001253029A1 (en)
WO (1) WO2001074847A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2689512T3 (en) * 2011-09-15 2018-11-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors that recognize MAGE restricted by HLA-A1 or HLA-Cw7

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060257A (en) * 1994-06-03 2000-05-09 Ludwig Institute For Cancer Research Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
CA2323632A1 (en) * 1998-03-13 1999-09-16 Epimmune Inc. Hla-binding peptides and their uses
WO1999061916A1 (en) * 1998-05-29 1999-12-02 Epimmune, Inc. Identification of broadly reactive dr restricted epitopes
IT1309584B1 (en) * 1999-02-26 2002-01-24 San Raffaele Centro Fond IMMUNOGENIC PEPTIDES DERIVED FROM MAGE-3 PRESENTED BY MHC OF CLASS II AND THEIR USE.
EP1917970B1 (en) * 1999-06-29 2011-06-15 Epimmune Inc. Hla binding peptides and their uses
CN1402782A (en) * 1999-10-19 2003-03-12 路德维哥癌症研究院 MAGE-A12 antigenic peptides and uses thereof

Also Published As

Publication number Publication date
WO2001074847A2 (en) 2001-10-11
WO2001074847A3 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU3760100A (en) Immunostimulatory nucleic acids and antigens
EP1244465A4 (en) Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
AU2087401A (en) Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
WO1999058658A3 (en) Expression vectors for stimulating an immune response and methods of using the same
AU4959199A (en) Chemokines as adjuvants of immune response
AU2002252731A1 (en) Compositions and methods of double-targeting virus infections and cancer cells
AU2002242085A1 (en) Methods and compositions useful for stimulating an immune response
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
EP1235848A4 (en) Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions
AU2002330053A1 (en) Chemokines as adjuvants of immune response
AU2002250078A1 (en) Quantitative epstein barr virus pcr rapid assay
AU2002219988A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2001261005A1 (en) Immune mediators and related methods
AU2002243972A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2001297741A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AU2001253029A1 (en) T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer
AU2002347464A1 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2088701A (en) Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
AU2289799A (en) Vaccine composition comprising milled lyophilisate of antigenic whole cells
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
AU2002220262A1 (en) Sdf-1 beta expressing tumor cells as tumor vaccines
AU2001274815A1 (en) Compositions and methods for inducing activation of dendritic cells
AU2001297804A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002259005A1 (en) Compositions and methods for inducing cancer cell death